Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 441 | 988 | 338 | 509 | 507 |
| Cost of Goods | 243 | 387 | 164 | 187 | 207 |
| Gross Profit | 198 | 601 | 173 | 322 | 300 |
| Operating Expenses | 1,201 | 1,807 | 1,820 | 2,075 | 1,781 |
| Operating Income | -1,003 | -1,206 | -1,646 | -1,752 | -1,480 |
| Other Income | -1 | 6 | -9 | -14 | 8 |
| Pre-tax Income | -1,004 | -1,200 | -1,656 | -1,766 | -1,472 |
| Net Income Continuous | -1,004 | -1,200 | -1,656 | -1,766 | -1,472 |
| Net Income | $-1,004 | $-1,200 | $-1,656 | $-1,766 | $-1,472 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EBITDA(a) | $-953 | $-1,118 | $-1,590 | $-1,710 | $-1,422 |